Us Congress 2023-2024 Regular Session

Us Congress House Bill HB301

Introduced
1/11/23  

Caption

Unmasking the Origins of COVID-19 Act This bill authorizes the Department of State to pay a reward for information leading to the identification of the origins of COVID-19 or other related information, such as the identification of individuals or entities involved in a cover-up of the origins of COVID-19.

Impact

Should HB301 be enacted, it could significantly alter how the U.S. government conducts investigations into health crises and the origins of infectious diseases. By offering financial incentives for information disclosure, the bill could encourage whistleblowing and the sharing of sensitive information that might otherwise remain unreported. Furthermore, the implications of this approach could increase pressure on foreign entities, particularly in light of U.S.-China relations and scrutiny over their research practices. The bill represents an effort to ensure accountability and transparency regarding public health matters that have global ramifications.

Summary

House Bill 301, also known as the 'Unmasking the Origins of COVID-19 Act', seeks to amend the State Department Basic Authorities Act of 1956. The bill allows the Department of State to provide rewards for credible information that leads to the identification of the origins of COVID-19. Additionally, it aims to uncover details about individuals or entities that may have been involved in a cover-up regarding the virus's origins and gain-of-function research linked to Chinese laboratories, specifically the Wuhan Institute of Virology. This legislative move is motivated by ongoing public interest and skepticism regarding the origins of the pandemic and associated governmental transparency.

Contention

The introduction of HB301 has stirred some contention, particularly in terms of its potential impact on diplomatic relations and international cooperation on health security. Critics may argue that such measures could exacerbate tensions with China and complicate collaborative efforts essential for managing global health threats. Supporters, however, posit that the pursuit of the truth is paramount, especially in light of the extensive public health impacts of COVID-19. The political debates surrounding the bill may hinge on broader issues of national security, ethics in scientific research, and the accountability of governmental institutions.

Companion Bills

No companion bills found.

Previously Filed As

US HB5379

HHS COVID–19 Origin Transparency Act of 2023

US SB619

COVID–19 Origin Act of 2023

US SB2754

HHS COVID–19 Origin Transparency Act of 2023

US HB1376

COVID–19 Origin Act of 2023

US HB1346

COVID–19 Origin Act of 2023

US HB118

No Vaccine Passports Act This bill prohibits certain actions related to vaccine passports and proof of COVID-19 vaccination. Specifically, a federal agency may not issue a vaccine passport, vaccine pass, or other standardized documentation for the purpose of certifying the COVID-19 vaccination status of a U.S. citizen to a third party, or otherwise publish or share any COVID-19 vaccination record of a U.S. citizen or similar health information. Additionally, proof of COVID-19 vaccination shall not be required to access federal or congressional property or services.

US HR337

Original Fair Housing Resolution of 2023

US HB72

This bill prohibits the use of federal funds to maintain a database or collect information that can be used to identify an individual's COVID-19 (i.e., coronavirus disease 2019) vaccination status.

US HB5223

Original Open for Business Act of 2023

US HB271

Restoring Normalcy in America Act This bill provides civil rights and employment protections for individuals based on their refusal to receive a COVID-19 vaccine and addresses other matters concerning the COVID-19 pandemic. Specifically, the bill prohibits discrimination in places of public accommodation and in federally assisted programs based on an individual's COVID-19 vaccine refusal. In addition, the bill prohibits employers from discriminating against such individuals, including discrimination related to hiring, compensation, advancement, or other employment opportunities. Further, the bill makes it unlawful for an employer to fail to offer any employee who was discharged for a COVID-19 vaccine refusal a position at an equal level and rate of pay to the position the employee held prior to discharge. In particular, the bill provides for the reinstatement of any member of the Armed Forces or federal employee who was involuntarily separated because of a COVID-19 vaccine refusal at the request of an affected individual. Any adverse action related to a COVID-19 vaccine refusal must be removed from an affected individual's military record or personnel file. Additionally, the bill (1) terminates the authority of the Food and Drug Administration to authorize under emergency procedures any drugs, biological products, or devices to prevent or treat COVID-19; and (2) requires the Department of Health and Human Services to study the effectiveness of COVID-19 vaccines and treatments, preparedness for future pandemics, and related matters. The Government Accountability Office must also audit certain federal funding for COVID-19 activities and programs.

Similar Bills

No similar bills found.